These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3031504)

  • 1. Glycine-binding sites and NMDA receptors in brain.
    Bowery NG
    Nature; 1987 Mar 26-Apr 1; 326(6111):338. PubMed ID: 3031504
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoradiographic localization of 3H-dextromethorphan binding sites differs from NMDA.
    Tortella FC; Davey R; Pellicano M; Bowery NG
    NIDA Res Monogr; 1989; 95():548-9. PubMed ID: 2561854
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of NG-nitro-L-arginine on age-related changes of glutamate receptor systems and immunophilin in rats.
    Araki T; Oshima Y; Kato H; Shuto K; Itoyama Y
    Methods Find Exp Clin Pharmacol; 1997; 19(6):373-81. PubMed ID: 9385586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonketotic hyperglycinemia: pathophysiological role of NMDA-type excitatory amino acid receptors.
    McDonald JW; Johnston MV
    Ann Neurol; 1990 Apr; 27(4):449-50. PubMed ID: 2162146
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.
    Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
    J Pharmacol Exp Ther; 2004 Sep; 310(3):933-42. PubMed ID: 15121761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
    Li YH; Han TZ
    J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
    Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of 4-hydroxy-3-nitroquinolin-2(1H)-ones as novel antagonists at the glycine site of N-methyl-D-aspartate receptors.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4682-6. PubMed ID: 8917657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel structure having antagonist actions at both the glycine site of the N-methyl-D-aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization.
    Snell LD; Claffey DJ; Ruth JA; Valenzuela CF; Cardoso R; Wang Z; Levinson SR; Sather WA; Williamson AV; Ingersoll NC; Ovchinnikova L; Bhave SV; Hoffman PL; Tabakoff B
    J Pharmacol Exp Ther; 2000 Jan; 292(1):215-27. PubMed ID: 10604951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic heteroaromatic systems. 3-substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]-quinoxalines as novel antagonists at the glycine-NMDA site.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Farmaco; 1997 Mar; 52(3):179-82. PubMed ID: 9212452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
    Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
    Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.
    Rowley M; Kulagowski JJ; Watt AP; Rathbone D; Stevenson GI; Carling RW; Baker R; Marshall GR; Kemp JA; Foster AC; Grimwood S; Hargreaves R; Hurley C; Saywell KL; Tricklebank MD; Leeson PD
    J Med Chem; 1997 Dec; 40(25):4053-68. PubMed ID: 9406596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL; Barr BM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
    Yang CR; Svensson KA
    Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.
    Baron BM; Siegel BW; Harrison BL; Gross RS; Hawes C; Towers P
    J Pharmacol Exp Ther; 1996 Oct; 279(1):62-8. PubMed ID: 8858976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.
    Buchstaller HP; Siebert CD; Steinmetz R; Frank I; Berger ML; Gottschlich R; Leibrock J; Krug M; Steinhilber D; Noe CR
    J Med Chem; 2006 Feb; 49(3):864-71. PubMed ID: 16451052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
    Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
    J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.